Pluristem Therapeutics Receives Patent In India For Cell Therapy Production Methods And Compositions

HAIFA, Israel, June 16, 2014 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, today announced it has been granted Patent No. 261087 from India's Office of the Controller General of Patents, Designs & Trade Marks for a patent titled, "Methods for Cell Expansion and Conditioned Media Produced Thereby for Therapy."

Help employers find you! Check out all the jobs and post your resume.